Search alternatives:
significant education » significant reduction (Expand Search), significant duration (Expand Search), significant reductions (Expand Search)
changes decrease » change increases (Expand Search), largest decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
education based » location based (Expand Search), education classes (Expand Search), population based (Expand Search)
Showing 61 - 80 results of 39,419 for search '(( significant ((changes decrease) OR (larger decrease)) ) OR ( significant education based ))', query time: 1.41s Refine Results
  1. 61
    Real-Time Polymer Viscosity–Catalytic Activity Relationships on the Microscale

    Real-Time Polymer Viscosity–Catalytic Activity Relationships on the Microscale by Or Eivgi (1677280)

    Published 2022
    “…Consistent with this diffusional-access model, these viscosity changes were found to be monomer-dependent, showing larger changes in microenvironment viscosity in cross-linked polydicyclopentadiene compared to non-crosslinked polynorbornene. …”
    Save to List
    Saved in:
  2. 62
    Real-Time Polymer Viscosity–Catalytic Activity Relationships on the Microscale

    Real-Time Polymer Viscosity–Catalytic Activity Relationships on the Microscale by Or Eivgi (1677280)

    Published 2022
    “…Consistent with this diffusional-access model, these viscosity changes were found to be monomer-dependent, showing larger changes in microenvironment viscosity in cross-linked polydicyclopentadiene compared to non-crosslinked polynorbornene. …”
    Save to List
    Saved in:
  3. 63
    Educational intervention designed based on the Fogg model.

    Educational intervention designed based on the Fogg model. by Fatemeh Mohseni (15258562)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 64
    Gut richness and diversity decrease significantly by week 5 of chemoradiotherapy.

    Gut richness and diversity decrease significantly by week 5 of chemoradiotherapy. by Molly B. El Alam (10231830)

    Published 2021
    Save to List
    Saved in:
  5. 65
    Significance of ADRs related facilitators based on demographic characteristics.

    Significance of ADRs related facilitators based on demographic characteristics. by Rabia Hussain (195190)

    Published 2022
    Save to List
    Saved in:
  6. 66
    Significance of ADRs related barriers based on demographic characteristics.

    Significance of ADRs related barriers based on demographic characteristics. by Rabia Hussain (195190)

    Published 2022
    Save to List
    Saved in:
  7. 67
    Predicted August maximum seven day average of daily maximum stream temperatures (7-DADM, °C) under natural potential (mature tree heights, no climate change) conditions, as well as the current, mid- and late-century no-action scenarios.

    Predicted August maximum seven day average of daily maximum stream temperatures (7-DADM, °C) under natural potential (mature tree heights, no climate change) conditions, as well as... by Caleb B. Fogel (12858982)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  8. 68
    Scheffe post-hoc.

    Scheffe post-hoc. by Nina Brkić-Jovanović (18886883)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 69
    MANCOVA’s main and interactive effect results.

    MANCOVA’s main and interactive effect results. by Nina Brkić-Jovanović (18886883)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 70
    S1 File -

    S1 File - by Nina Brkić-Jovanović (18886883)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 71
    Changes in FMD (% ± SD) in patient subgroup with decreased body weight during observation period.

    Changes in FMD (% ± SD) in patient subgroup with decreased body weight during observation period. by Haruka Tamura (153793)

    Published 2022
    Save to List
    Saved in:
  12. 72
    Each square gives extinction probability p (AB) or median population change d (CD) for 100 simulations at .

    Each square gives extinction probability p (AB) or median population change d (CD) for 100 simulations at . by Alexandra M. Campbell (3284094)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 73
    Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  14. 74
    Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  15. 75
    Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  16. 76
    Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  17. 77
    Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  18. 78
    Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  19. 79
    Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  20. 80
    Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:

Search Tools: